NEW YORK (GenomeWeb News) – Suregene said last week that it has received a $497,000 grant from the National Institute of Mental Health to develop a test for the early detection of schizophrenia.

According to the company, the test focuses on two genetic variations observed in some patients with the mental disorder. The company hopes the test will allow physicians to gauge the risk of a patient developing schizophrenia, as well as help with the development of personalized therapies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.